Wendy Holman Joins Sabin Vaccine Institute Board of Trustees

WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Wendy Commins Holman to its Board of Trustees. Ms. Holman is the CEO and founder of Ridgeback Biotherapeutics, a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases.

Dr. Jan Holmgren Receives 2017 Albert B. Sabin Gold Medal Award

WASHINGTON, D.C. – April 25, 2017 – Tonight, the Sabin Vaccine Institute (Sabin) will honor Dr. Jan Holmgren with the 2017 Albert B. Sabin Gold Medal Award. Dr. Holmgren will be recognized for his pioneering contributions to oral vaccine research and mucosal immunology, as well as his leadership in the discovery of the world's first effective oral cholera vaccine.

Public Health Experts Discuss Vaccines, Antibiotic Resistance and Surveillance at Conference on Typhoid and Other Invasive Salmonelloses

KAMPALA, UGANDA – April 4, 2017 – Today, the Sabin Vaccine Institute opened the 10th International Conference on Typhoid and Other Invasive Salmonelloses in Kampala, Uganda. Over the course of the three day conference, more than 300 experts from around the world have gathered to discuss new typhoid-related research, as well as how to turn this evidence into action in the fight against typhoid.

European Leaders Gather in Georgia for Regional Workshop on Immunization Legislation

TBILISI, GEORGIA — March 1, 2017 — Today, the Sabin Vaccine Institute and the Government of Georgia assembled senior officials from Armenia, Georgia and Moldova to develop legislative roadmaps that will support the sustainability of national immunization programs to protect more than 16.6 million people.

Sabin Vaccine Institute Names Deputy Assistant Secretary for Health as New President of Global Immunization

WASHINGTON, D.C., February 13, 2017 – Sabin Vaccine Institute (Sabin), a non-profit dedicated to making life-improving vaccines more accessible, enabling innovation and expanding immunization across the globe, today announced the appointment of Dr. Bruce Gellin as President, Global Immunization. Dr. Gellin, a 15-year U.S. Department of Health and Human Services (HHS) veteran, has served as Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office since 2002. Among his roles, Dr. Gellin led discussions on behalf of the United States at high-level global and domestic policy advisory groups and was responsible for developing the National Vaccine Plan, our country's blueprint for all aspects of vaccines and immunization.

The International Association of Immunization Managers Hosts Discussions on Vaccine Confidence During Regional Meeting

Madrid, Spain — February 1, 2017 — Today, the International Association of Immunization Managers (IAIM), based at the Sabin Vaccine Institute (Sabin), began its first-ever regional meeting for members from the Americas and Europe. Immunization experts from around the world have gathered to discuss vaccine acceptance and demand, as well as how to measure vaccine knowledge and perceptions, over the course of the two-day conference.

Sabin Vaccine Institute Joins Coalition Dedicated to Preventing Future Epidemics

Geneva, Switzerland – November 18, 2016 – Today, the Sabin Vaccine Institute (Sabin) begins its formal membership with the Coalition for Epidemic Preparedness Innovations (CEPI), as global health leaders gather in Geneva, Switzerland for the first meeting of CEPI’s Joint Coordination Group (JCG).

Pope Francis, Sabin President Discuss Goals of the Catholic Church during Conference on Neglected Tropical Diseases

Vatican City – November 10, 2016 –Peter Hotez, M.D., Ph.D., president of the Sabin Vaccine Institute (Sabin) and director of the Sabin Product Development Partnership (Sabin PDP), today will help kick off the first-ever Vatican conference on neglected tropical diseases (NTDs) and rare diseases with a keynote address.

In Memoriam: Heloisa Sabin

WASHINGTON, D.C. – October 17, 2016 – The Sabin Vaccine Institute joins a global community of friends, partners and global health advocates in celebrating the life of Heloisa Sabin, (née Dunshee de Abranches) who passed away October 12 at the age of 98. Wife of the late Dr. Albert B. Sabin, who developed the oral live virus polio vaccine, Heloisa Sabin shared her late husband’s dedication to the elimination of needless human suffering and poverty.

The International Association of Immunization Managers Holds Inaugural Joint Regional Meeting in Beijing

Beijing, China — September 22, 2016 — The International Association of Immunization Managers (IAIM), based at the Sabin Vaccine Institute (Sabin), today began its first-ever regional meeting for members from Asia and the Pacific in Beijing, China.

Pages